Published in Rheumatology (Oxford) on July 16, 2003
Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis. Arthritis Rheum (2007) 1.72
Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury. Hepatology (2008) 1.53
Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathies. J Clin Invest (2015) 1.51
Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index. Arthritis Rheum (2009) 1.30
A national registry for juvenile dermatomyositis and other paediatric idiopathic inflammatory myopathies: 10 years' experience; the Juvenile Dermatomyositis National (UK and Ireland) Cohort Biomarker Study and Repository for Idiopathic Inflammatory Myopathies. Rheumatology (Oxford) (2010) 1.29
The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis. Ann Rheum Dis (2012) 1.15
The Paediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis. Arthritis Care Res (Hoboken) (2010) 1.05
Changes in novel biomarkers of disease activity in juvenile and adult dermatomyositis are sensitive biomarkers of disease course. Arthritis Rheum (2012) 1.00
Comparison of children with onset of juvenile dermatomyositis symptoms before or after their fifth birthday in a UK and Ireland juvenile dermatomyositis cohort study. Arthritis Care Res (Hoboken) (2012) 1.00
Criteria to define response to therapy in paediatric rheumatic diseases. Eur J Clin Pharmacol (2010) 0.95
Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease. Ann Rheum Dis (2013) 0.88
Resistin in idiopathic inflammatory myopathies. Arthritis Res Ther (2012) 0.86
Concomitant diseases in a cohort of patients with idiopathic myositis during long-term follow-up. Clin Rheumatol (2009) 0.85
Clinical characteristics and favorable long-term outcomes for patients with idiopathic inflammatory myopathies: a retrospective single center study in China. BMC Neurol (2011) 0.84
New insights into the benefits of exercise for muscle health in patients with idiopathic inflammatory myositis. Curr Rheumatol Rep (2014) 0.84
Serum level of soluble CX3CL1/fractalkine is elevated in patients with polymyositis and dermatomyositis, which is correlated with disease activity. Arthritis Res Ther (2012) 0.83
Magnetic resonance measurement of muscle T2, fat-corrected T2 and fat fraction in the assessment of idiopathic inflammatory myopathies. Rheumatology (Oxford) (2015) 0.83
Dysfunction of endothelial progenitor cells is associated with the type I IFN pathway in patients with polymyositis and dermatomyositis. Rheumatology (Oxford) (2016) 0.82
Improved exercise performance and increased aerobic capacity after endurance training of patients with stable polymyositis and dermatomyositis. Arthritis Res Ther (2013) 0.81
Treatment of inflammatory myopathies. Postgrad Med J (2006) 0.81
Juvenile dermatomyositis: new insights and new treatment strategies. Ther Adv Musculoskelet Dis (2012) 0.81
Mycophenolate mofetil in juvenile dermatomyositis: a case series. Rheumatol Int (2010) 0.80
The metastasis promoting protein S100A4 levels associate with disease activity rather than cancer development in patients with idiopathic inflammatory myopathies. Arthritis Res Ther (2014) 0.80
Increased levels of eotaxin and MCP-1 in juvenile dermatomyositis median 16.8 years after disease onset; associations with disease activity, duration and organ damage. PLoS One (2014) 0.79
Patient preference assessment reveals disease aspects not covered by recommended outcomes in polymyositis and dermatomyositis. ISRN Rheumatol (2011) 0.79
Analysis of Published Criteria for Clinically Inactive Disease in a Large Juvenile Dermatomyositis Cohort Shows That Skin Disease Is Underestimated. Arthritis Rheumatol (2015) 0.79
Treatment of inflammatory myopathy: emerging therapies and therapeutic targets. Expert Rev Clin Immunol (2015) 0.78
Quantitative T cell subsets profile in peripheral blood from patients with idiopathic inflammatory myopathies: tilting the balance towards proinflammatory and pro-apoptotic subsets. Clin Exp Immunol (2015) 0.78
Novel assessment tools to evaluate clinical and laboratory responses in a subset of patients enrolled in the Rituximab in Myositis trial. Clin Exp Rheumatol (2014) 0.78
Health-related quality of life and well-being in adults with idiopathic inflammatory myopathy. Clin Rheumatol (2014) 0.78
Idiopathic inflammatory myopathies: current and future therapeutic options. Neurotherapeutics (2008) 0.77
Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II Trial. PLoS One (2015) 0.76
213th ENMC International Workshop: Outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18-20 September 2015. Neuromuscul Disord (2016) 0.76
Modern Therapies for Idiopathic Inflammatory Myopathies (IIMs): Role of Biologics. Clin Rev Allergy Immunol (2016) 0.76
Comparison of the Utility and Validity of Three Scoring Tools to Measure Skin Involvement in Patients With Juvenile Dermatomyositis. Arthritis Care Res (Hoboken) (2016) 0.75
Voluntary activation failure is detectable in some myositis patients with persisting quadriceps femoris weakness: an observational study. Arthritis Res Ther (2006) 0.75
Expression of tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 in patients with polymyositis and dermatomyositis. Arthritis Res Ther (2014) 0.75
On Determining the Effects of Therapy on Disease Damage in Non- randomized Studies with Multiple Treatments: A study of Juvenile Myositis. Commun Stat Theory Methods (2009) 0.75
The clinical utility of serum IL-35 in patients with polymyositis and dermatomyositis. Clin Rheumatol (2016) 0.75
Comparison of clinical, serological, and prognostic differences among juvenile-, adult-, and late-onset lupus nephritis in Korean patients. Clin Rheumatol (2017) 0.75
Estimating African American admixture proportions by use of population-specific alleles. Am J Hum Genet (1998) 22.90
Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat Genet (1999) 17.09
Strength-duration curves for repetitive stimulation of medullated nerve. J Physiol (1934) 15.94
Influence of clinician workload and patterns of treatment on survival from breast cancer. Lancet (1995) 10.99
Integration of cytogenetic landmarks into the draft sequence of the human genome. Nature (2001) 10.96
Methods to increase response rates to postal questionnaires. Cochrane Database Syst Rev (2007) 7.13
Growth of factor-dependent hemopoietic precursor cell lines. J Exp Med (1980) 5.80
Senior house officer training: is it getting better? A questionnaire survey. BMJ (1997) 5.61
THE SYNTHESIS OF HEMOGLOBIN IN A CELL-FREE SYSTEM. Proc Natl Acad Sci U S A (1958) 4.92
Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ (1999) 4.66
Ferritin in the serum of normal subjects and patients with iron deficiency and iron overload. Br Med J (1972) 4.60
A dust-obscured massive maximum-starburst galaxy at a redshift of 6.34. Nature (2013) 4.43
The biological concept of race and its application to public health and epidemiology. J Health Polit Policy Law (1986) 4.02
The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. Rheumatology (Oxford) (2002) 3.87
Pupil-led sex education in England (RIPPLE study): cluster-randomised intervention trial. Lancet (2004) 3.86
Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA. N Engl J Med (1999) 3.76
Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell (1998) 3.72
Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol (1998) 3.68
Characterization of a human macroglobulin. II. Distribution of the disulfide bonds. J Biol Chem (1965) 3.64
Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J Cell Biol (2000) 3.53
Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial. Ann Rheum Dis (2008) 3.45
Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet (2001) 3.39
Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial. Lancet (1999) 3.25
Application of operant conditioning procedures to the behavior problems of an autistic child: a follow-up and extension. Behav Res Ther (1967) 3.23
Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med (1986) 3.22
Hot spot focusing of somatic hypermutation in MSH2-deficient mice suggests two stages of mutational targeting. Immunity (1998) 3.16
Evaluation of a serologic marker, CA19-9, in the diagnosis of pancreatic cancer. Ann Intern Med (1989) 3.02
Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. Neurology (2008) 2.87
Agmatine: an endogenous clonidine-displacing substance in the brain. Science (1994) 2.83
Heatstroke in well-wrapped infants. Lancet (1979) 2.81
WWOX: a candidate tumor suppressor gene involved in multiple tumor types. Proc Natl Acad Sci U S A (2001) 2.79
European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis (2011) 2.74
Does it matter where you live? Treatment variation for breast cancer in Yorkshire. The Yorkshire Breast Cancer Group. Br J Cancer (1995) 2.71
Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis (2001) 2.69
Trends in hospitalization rates for heart failure in the United States, 1973-1986. Evidence for increasing population prevalence. Arch Intern Med (1990) 2.65
Precipitating factors leading to decompensation of heart failure. Traits among urban blacks. Arch Intern Med (1988) 2.65
Assessment of the association between habitual salt intake and high blood pressure: methodological problems. Am J Epidemiol (1979) 2.56
Adjuvant active specific immunotherapy for human colorectal cancer: 6.5-year median follow-up of a phase III prospectively randomized trial. J Clin Oncol (1993) 2.50
Craniopagus parasiticus. Everard Home's Two-Headed Boy of Bengal and some other cases. Surg Neurol (1989) 2.50
Group A beta-hemolytic streptococci resistant to erythromycin and lincomycin. N Engl J Med (1968) 2.44
Recovery of human ova from the uterine tubes. J Am Med Assoc (1928) 2.43
The treatment of Wilms' tumor: results of the Second National Wilms' Tumor Study. Cancer (1981) 2.43
A note on the biologic concept of race and its application in epidemiologic research. Am Heart J (1984) 2.43
The DNA sequence and biological annotation of human chromosome 1. Nature (2006) 2.42
BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus. Rheumatology (Oxford) (2005) 2.37
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial. JAMA (1999) 2.36
Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study. Ann Rheum Dis (2008) 2.35
Bilateral human fetal striatal transplantation in Huntington's disease. Neurology (2002) 2.34
Cerebral arteriovenous oxygen difference as an estimate of cerebral blood flow in comatose patients. J Neurosurg (1989) 2.32
Autogenous immunity to endogenous RNA tumor virus. Radioimmune precipitation assay of mouse serum antibody levels. J Exp Med (1973) 2.31
Determinants of mortality from cystic fibrosis in Canada, 1970-1989. Am J Epidemiol (1996) 2.28
Citrullination is an inflammation-dependent process. Ann Rheum Dis (2006) 2.25
Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II. J Biol Chem (1998) 2.24
Bovine beta-lactoglobulin at 1.8 A resolution--still an enigmatic lipocalin. Structure (1997) 2.23
Coronary arteriography and coronary bypass survey among whites and other racial groups relative to hospital-based incidence rates for coronary artery disease: findings from NHDS. Am J Public Health (1989) 2.21
Localization of 125I-labeled antigen in germinal centers of mouse spleen: histologic and ultrastructural autoradiographic studies of the secondary immune reaction. J Immunol (1968) 2.21
Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial. Diabetes Obes Metab (2009) 2.19
Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum (2007) 2.18
Re: Lung cancer case-control study of beryllium workers. Sanderson WT, Ward EM, Steenland K, Petersen MR. Am. J. Ind. Med. 2001. 39:133-144. Am J Ind Med (2001) 2.17
Methane-oxidizing microorganisms. Microbiol Rev (1981) 2.17
Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial. Ann Intern Med (1996) 2.17
Rising death rates in the Soviet Union: the impact of coronary heart disease. N Engl J Med (1981) 2.17
Very short patch mismatch repair in phage lambda: repair sites and length of repair tracts. Genetics (1986) 2.17
The primary periodic paralyses: diagnosis, pathogenesis and treatment. Brain (2005) 2.17
Divergence of the recent trends in coronary mortality for the four major race-sex groups in the United States. Am J Public Health (1988) 2.16
Lateral column lengthening as treatment for planovalgus foot deformity in ambulatory children with spastic cerebral palsy. J Pediatr Orthop (2000) 2.14
Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. Proc Natl Acad Sci U S A (2000) 2.13
Immune deficiency syndrome in children. JAMA (1983) 2.12
Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis (2008) 2.12
Endoscopic ultrasound in the evaluation of Barrett's esophagus: a preliminary report. Am J Gastroenterol (1994) 2.11
How should different life expectancies be valued? BMJ (1998) 2.10
Autogenous immunity to endogenous RNA tumor virus. Identification of antibody reactivity to select viral antigens. J Exp Med (1974) 2.10
Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med (1997) 2.04
Cigarette smoking and ill health among black Americans. N Y State J Med (1985) 2.04
BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatology (Oxford) (2007) 2.02
Predicting readmission to the psychiatric hospital in a managed care environment: implications for quality indicators. Am J Psychiatry (1997) 2.02
Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force. Ann Rheum Dis (2007) 2.01
Standardization of blood pressure measurement in an international comparative study. J Clin Epidemiol (1996) 1.99
Cloning and expression of steroid sulfatase cDNA and the frequent occurrence of deletions in STS deficiency: implications for X-Y interchange. Cell (1987) 1.99
Potential mechanism of emphysema: alpha 1-proteinase inhibitor recovered from lungs of cigarette smokers contains oxidized methionine and has decreased elastase inhibitory capacity. Proc Natl Acad Sci U S A (1982) 1.99
Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France. J Virol (1995) 1.99
Mobilization and collection of peripheral blood CD34+ cells from patients with Fanconi anemia. Blood (2001) 1.98
Enduring impact of communication skills training: results of a 12-month follow-up. Br J Cancer (2003) 1.98
Neurological channelopathies. Postgrad Med J (2005) 1.98
Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford) (2001) 1.96
Fifty years of anti-ds DNA antibodies: are we approaching journey's end? Rheumatology (Oxford) (2007) 1.95
Tuberculosis in young adults and the elderly. A prospective comparison study. Chest (1994) 1.94
The bicarbonate ion pump in the endothelium which regulates the hydration of rabbit cornea. J Physiol (1976) 1.94
Endomysial antibody: is it the best screening test for coeliac disease? Gut (1992) 1.93
The decline in mortality from coronary heart disease, U.S.A., 1968--1975. J Chronic Dis (1978) 1.92
Impact of orthoses on the rate of scoliosis progression in children with cerebral palsy. J Pediatr Orthop (1996) 1.91
Primary episodic ataxias: diagnosis, pathogenesis and treatment. Brain (2007) 1.91
Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheum Dis (2004) 1.90
[Compartmental dispersion of enzymes in rat liver mitochondria]. Eur J Biochem (1968) 1.86
The ultrastructure of antigen localization and viruslike particles in mouse spleen germinal centers. Exp Mol Pathol (1968) 1.86